Junevity
Junevity is a longevity biotechnology company developing Cell Reset therapeutics, a new class of medicines reversing transcriptional damage with siRNA. The RESET Platform is the first to use large-scale human data and AI to develop novel siRNA therapeutics targeting transcription factors. Founded out of UCSF in 2023, Junevity’s mission is to extend human lifespan and healthspan.
junevity.com
11-50 employees
Live Data Stream
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats